Can This IPO Shake Up the Pharmaceutical Industry?
The initial public offering (IPO) of GoodRx (NASDAQ: GDRX) this week drew significant investor interest. Shares jumped almost 50% in the first day of trading, from an already lofty IPO price of $33.
Beyond its strong revenue growth and earnings, the company's mission moves healthcare in a direction that both political parties can agree on. The rare bipartisan support for reducing prescription drug prices in today's polarized political climate means that GoodRx is in a position to potentially shake up the pharmaceutical industry.
Image source: Getty Images.
Source Fool.com
